rel-(3R,4S)-1-(tert-Butoxycarbonyl)-4-(p-tolyl)pyrrolidine-3-carboxylic acid, 98%, 5g

Ethyl 1-methyl-3-(trifluoromethyl)pyrazole-4-carboxylate, 98.0%, 1g

Gallic acid monohydrate, min. 99%, 500 g, plastic packaging.

TRANS-STILBENE, 95%, 5g

m-Tolyl-acetyl chloride, 95.0%, 2g

tert-Butyl 4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl)piperazine-1-carboxylate, 96%, 5g

tert-Butyl (S)-3-amino-2-(((benzyloxy)carbonyl)amino)propanoate, 97%, 25g

(S)-4-(4-((4-Chlorophenyl)(pyridin-2-yl)methoxy)piperidin-1-yl)butanoic acid compound with benzenesulfonic acid (1:1), 98%, 1g

tert-Butyl 5,8-diazaspiro[3.5]nonane-8-carboxylate, 95.0%, 250mg

1-Butyl-4-methylpyridinium Bis(trifluoromethanesulfonyl)imide>98.0%(HPLC)(T)1g

N-(4-Chloro-3-hydroxyphenyl)acetamide, 95.0%, 10g

2,2-Bis[3,5-dibromo-4-(2,3-dibromopropoxy)phenyl]propane>95.0%(T)500g

METHYL 3-BROMO-2,6-DIMETHYLBENZOATE, 95.0%, 10g